reference/15388397

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15388397

Outgoing Links

Predicate	Object
contentType	Controlled Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	42
issn	1099-1077 0885-6222
issueIdentifier	1
pageRange	39-42
publicationName	Human Psychopharmacology: Clinical and Experimental
startingPage	39
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d0499c9c47d49edfe884ae0aacef7dac http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8ae9c3496191f3ca554f2e43b34fd7a3
bibliographicCitation	Suzuki Y, Fukui N, Watanabe J, Ono S, Sugai T, Tsuneyama N, Saito M, Inoue Y, Someya T. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone. Hum Psychopharmacol. 2012 Jan;27(1):39–42. doi: 10.1002/hup.1258. PMID: 22144033.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4c39600e9bf3de5c67c00121796716df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27a23c887bb49cca6b73c2b8ffbd6669 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65a8b95b8544ed0ed28d9b45dad8d57f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9e880806516d8745bc0fdf7dd03b635 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a93aaf553f75ee4172ad3a0b078cbd8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d461ec1f6ae96cf875c82c1ac92fc27 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_447ba0b363bbebdf4ea4322c25d540fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2999c6bf492f92e8c42fd288b96295a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b22d0528a0c63593bbddfcab082f470
date	2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22144033 https://doi.org/10.1002/hup.1258
isPartOf	https://portal.issn.org/resource/ISSN/1099-1077 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30067 https://portal.issn.org/resource/ISSN/0885-6222
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	QT prolongation of the antipsychotic risperidone is predominantly related to its 9‐hydroxy metabolite paliperidone
discusses	http://id.nlm.nih.gov/mesh/M0546009 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0021770 http://id.nlm.nih.gov/mesh/M0028338 http://id.nlm.nih.gov/mesh/M0011807
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011743Q000009 http://id.nlm.nih.gov/mesh/D007555Q000009 http://id.nlm.nih.gov/mesh/D018967Q000009 http://id.nlm.nih.gov/mesh/D008133Q000139 http://id.nlm.nih.gov/mesh/D014150Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D004562 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D011743Q000493 http://id.nlm.nih.gov/mesh/D007555Q000493 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000367 http://id.nlm.nih.gov/mesh/D018967Q000493 http://id.nlm.nih.gov/mesh/D018967Q000008 http://id.nlm.nih.gov/mesh/D014150Q000008 http://id.nlm.nih.gov/mesh/D014150Q000493 http://id.nlm.nih.gov/mesh/D000068882 http://id.nlm.nih.gov/mesh/D055815
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9922 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5073 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8355 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115237

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129101897 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136236526

Total number of triples: 62.